E xEtrac is a novel hypothesis strengthening 'New Product' Risk Management Tool

• A specifically developed and tailored tool for the purpose of extending the Safety Knowledge as required of a Pharmacovigilance Plan
• Backed by peer reviewed publications and developed by acknowledged experts in the field of Pharmacoepidemiology
• Operates in a rapid manner giving up-to-date data and information related to the expressed requirements within the Pharmacovigilance Plan
• Operates in various modes depending upon needs - Risk side of the equation alone; risk and benefit mode at the same time; risk now, balanced against projected benefit where such benefits are longer term
• Has data streams from key countries that are often first to launch
• Uses existing data or a tailored data collection methodology
• Is tailored to suit each use. Each study has its own sponsor approved protocol
• Highly cost effective methodology

ExEtrac a product of the GPRD Group at the MHRA

ExEtrac is a registered trade mark

Want to know more? Email: